Axial Spondyloarthritis/Ankylosing Spondylitis Studies

​The Division of Rheumatology strives to understand more about Spondyloarthritis through research. Please see the list below, which summarizes the studies available to individuals interested in advancing our understanding and treatment of rheumatic disease.

​Study Name/IRB#/PIBrief DescriptionBasic Eligibility CriteriaContact

Program for individuals 
with an Elevated Risk 
of Spondyloarthritis 
(PIERS)

17-0977

Liron Caplan, MD

​Long-term research 
study of individuals 
at risk of spondyloarthritis (SpA). 
This study does not 
include a place​bo group.
1) Parent, child, or sibling 
(by blood) of 
someone with 
spondyloarthritis
2) Individuals with SpA 
or SpA associated 
conditions such as 
inflammatory bowel 
disease, psoriasis, or 
uveitis)

Andrew Stahly

303-724-3539

Andrew.Shahly@CUAnchutz.edu

or click here to give your information to the study team.

Interdisciplinary Joint Biology Program for Rheumatic and Orthopedic Diseases

20-1908

Larry Moreland, MD

The goal of the University of Colorado Interdisciplinary Joint Biology Program is to employ cutting edge science and technology to advance research of inflammatory, degenerative and musculoskeletal joint diseases

Individuals with RA, SpA, PsA, AS, OA or any other form of inflammatory arthritis with active disease in their elbow, wrist, hand joints, knee, ankle or shoulder and are willing to undergo a synovial biopsy at that site

or

individuals who are having an orthopedic surgery and are willing to donate their tissues that would normally be discarded

Jennifer Seifert

303-724-7541

Jennifer.Seifert@UCAnschutz.edu

Or visit https://medschool.cuanschutz.edu/cuijbp

Classification of Axial SpondyloarthritiS Inception Cohort (CLASSIC) study

19-1526

Liron Caplan, MD

A study of chronic low back pain.  Experts in spondyloarthritis developed a system for identifying patients with back pain due to immune causes. This study test how this system (known as classification criteria) works in patients from North America.

Analysis ongoing, but closed to recruitment

Please note that study status changes frequently and therefore, a listed study may not be actively enrolling. Also, the complete list of inclusion and exclusion criteria for a given study is often not listed due to its length. A visit to determine an individual’s eligibility may be required. A placebo is an inactive substance or treatment that looks the same as, and is given the same way as, an active drug or treatment being tested. The effects of the active drug or treatment are compared to the effects of the placebo.
​​​​